The company needs licensing deals to show how the company differs from the traditional biotech model. Instos will then see the value when licensing royalties roll in. I don't see the value in more instos on the books to trade the stock price up and down.
Deals are the real deal!
The company needs licensing deals to show how the company...
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.005(2.04%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 25.5¢ | 24.5¢ | $5.409K | 21.88K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20748 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 8119 | 2 |
View Market Depth
| Last trade - 15.45pm 24/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |